Recent FDA approval of sofosbuvir and simeprevir. Implications for current HCV treatment
Author:
Publisher
Wiley
Subject
Hepatology
Reference13 articles.
1. Novel therapies for hepatitis C: insights from the structure of the virus;Fusco;Annu Rev Med,2012
2. Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977;Murakami;J Biol Chem,2010
3. Sofosbuvir for previously untreated chronic hepatitis C infection;Lawitz;N Engl J Med,2013
4. Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options;Jacobson;N Engl J Med,2013
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Single-molecule-binding studies of antivirals targeting the hepatitis C virus core protein;Journal of Virology;2023-10-31
2. Description and in silico ADME studies of US-FDA approved drugs or drugs under clinical trial which violate the Lipinski’s rule of 5;Letters in Drug Design & Discovery;2023-02-24
3. Machine Learning Model Validated to Predict Outcomes of Liver Transplantation Recipients with Hepatitis C: The Romanian National Transplant Agency Cohort Experience;Sensors;2023-02-14
4. Singlet oxygen and radical-mediated mechanisms in the oxidative cellular damage photosensitized by the protease inhibitor simeprevir;Free Radical Biology and Medicine;2023-01
5. Identifying Different Mutation Sites Leading to Resistance to the Direct-Acting Antiviral (DAA) Sofosbuvir in Hepatitis C Virus Patients from Egypt;Microorganisms;2022-03-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3